PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW087947View Pathway |
Thyroid Hormone SynthesisMus musculus
The thyroid hormones, triiodothyronine (T3) and thyroxine (T4), are tyrosine-based hormones produced by the thyroid gland that are primarily responsible for regulation of metabolism. Iodine is necessary for the production of T3 and T4. A deficiency of iodine leads to decreased production of T3 and T4, enlarges the thyroid tissue and will cause the disease known as goitre. The major form of thyroid hormone in the blood is thyroxine (T4), which has a longer half-life than T3. The ratio of T4 to T3 released into the blood is roughly 20 to 1. T4 is converted to the active T3 (three to four times more potent than T4) within cells by deiodinases (5'-iodinase). These are further processed by decarboxylation and deiodination to produce iodothyronamine (T1a) and thyronamine (T0a). All three isoforms of the deiodinases are selenium-containing enzymes, thus dietary selenium is essential for T3 production.
|
Creator: Ana Marcu Created On: August 09, 2018 at 18:11 Last Updated: August 09, 2018 at 18:11 |
PW131356View Pathway |
Thyrotropin Drug MetabolismHomo sapiens
|
Creator: Selena Created On: September 15, 2023 at 00:50 Last Updated: September 15, 2023 at 00:50 |
PW146990View Pathway |
Thyroxine Drug Metabolism PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 10, 2023 at 13:36 Last Updated: October 10, 2023 at 13:36 |
PW145007View Pathway |
drug action
Tiagabine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:54 Last Updated: October 07, 2023 at 14:54 |
PW176146View Pathway |
Tiagabine Predicted Metabolism Pathway newHomo sapiens
Metabolites of Tiagabine are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:18 Last Updated: November 29, 2023 at 14:18 |
PW128182View Pathway |
drug action
Tiapride Dopamine Antagonist Action PathwayHomo sapiens
Tiapride is a selective D2 and D3 dopamine receptor blocker indicated for the treatment of a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
|
Creator: Omolola Created On: July 28, 2023 at 13:23 Last Updated: July 28, 2023 at 13:23 |
PW128192View Pathway |
drug action
Tiapride Serotonin Antagonist Action PathwayHomo sapiens
Tiapride is a selective D2 and D3 dopamine receptor blocker indicated for the treatment of a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
|
Creator: Omolola Created On: August 01, 2023 at 09:20 Last Updated: August 01, 2023 at 09:20 |
PW000682View Pathway |
drug action
Tiaprofenic Acid Action PathwayHomo sapiens
Tiaprofenic Acid (also named tiaprofensaeure and surgam) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to treat pain (especially arthritic pain). Tiaprofenic can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of tiaprofenic.
|
Creator: WishartLab Created On: April 26, 2014 at 13:08 Last Updated: April 26, 2014 at 13:08 |
PW126090View Pathway |
drug action
Tiaprofenic Acid Action Pathway (New)Homo sapiens
Tiaprofenic acid is a nonsteroidal anti-inflammatory (NSAID) used to manage inflammation and analgesia associated with rheumatoid arthritis and osteoarthritis. Tiaprofenic acid possess anti-inflammatory, analgesic and antipyretic activity. It targets the prostaglandin G/H synthase-1 (COX-1) and prostaglandin G/H synthase-2 (COX-2) in the cyclooxygenase pathway. The cyclooxygenase pathway begins in the cytosol with phospholipids being converted into arachidonic acid by the action of phospholipase A2. The rest of the pathway occurs on the endoplasmic reticulum membrane, where prostaglandin G/H synthase 1 & 2 converts arachidonic acid into prostaglandin H2. Prostaglandin H2 can either be converted into thromboxane A2 via thromboxane A synthase, prostacyclin/prostaglandin I2 via prostacyclin synthase or prostaglandin E2 via prostaglandin E synthase. COX-2 is an inducible enzyme, and during inflammation, it is responsible for prostaglandin synthesis. It leads to the formation of prostaglandin E2 which is responsible for contributing to the inflammatory response by activating immune cells and for increasing pain sensation by acting on pain fibers. Tiaprofenic acid inhibits the action of COX-1 and COX-2 on the endoplasmic reticulum membrane. This reduces the formation of prostaglandin H2 and therefore, prostaglandin E2 (PGE2). The low concentration of prostaglandin E2 attenuates the effect it has on stimulating immune cells and pain fibers, consequently reducing inflammation and pain. Fever is triggered by inflammatory and infectious diseases. Cytokines are produced in the central nervous system (CNS) during an inflammatory response. These cytokines induce COX-2 production that increases the synthesis of prostaglandin, specifically prostaglandin E2 which adjusts hypothalamic temperature control by increasing heat production. Because tiaprofenic acid decreases PGE2 in the CNS, it has an antipyretic effect. Antipyretic effects results in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation.
|
Creator: Karxena Harford Created On: June 15, 2021 at 00:09 Last Updated: June 15, 2021 at 00:09 |
PW145467View Pathway |
drug action
Tiaprofenic acid Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:53 Last Updated: October 07, 2023 at 15:53 |